Investigational Site Number :0360001

Melbourne, Victoria 3010

0 studies enrolling now · 5 studies all time

What they study most

Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia Refractory, Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasia, COVID-19, Chronic Graft Versus Host Disease, Malignant Solid Tumor, Myelodysplastic Syndromes

Studies at this site

• First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) — Stopped early
• A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. — Running, not enrolling
• Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older — Stopped early
• A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies — Stopped early
• A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors — Completed